Stamatopoulos K

Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Visentin A, Gaffo E, Fürstenau M, ..., Trentin L, Bortoluzzi S

Leukemia 39 (12) 2957-2967 [2025-12-00; online 2025-09-19]

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Nadeu F, Shuai S, Clot G, ..., Puente XS, Campo E

Leukemia 39 (9) 2076-2086 [2025-09-00; online 2025-06-30]

The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.

Hägerstrand D, Oder B, Cortese D, ..., Sutton LA, Rosenquist R

Leukemia 38 (11) 2429-2442 [2024-11-00; online 2024-09-11]

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Visentin A, Chatzikonstantinou T, Scarfò L, ..., Stamatopoulos K, Ghia P

Am. J. Hematol. 98 (12) 1856-1868 [2023-12-00; online 2023-09-29]

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.

Bonfiglio S, Sutton LA, Ljungström V, ..., Rosenquist R, Ghia P

Blood Adv 7 (12) 2794-2806 [2023-06-27; online 2023-01-26]

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

Chatzikonstantinou T, Kapetanakis A, Scarfò L, ..., Stamatopoulos K, Ghia P

Leukemia 35 (12) 3444-3454 [2021-12-00; online 2021-11-01]

DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy.

Tsagiopoulou M, Papakonstantinou N, Moysiadis T, ..., Rosenquist R, Stamatopoulos K

Clin Epigenetics 11 (1) 177 [2019-12-02; online 2019-12-02]

Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.

Papakonstantinou N, Ntoufa S, Tsagiopoulou M, ..., Rosenquist R, Stamatopoulos K

Int. J. Cancer 144 (11) 2695-2706 [2019-06-01; online 2019-01-15]